Epigenetic Modification in Methylene Tetrahydrofolate Reductase (MTHFR) Gene of Women with Pre-eclampsia

V O Osunkalu; I A Taiwo; C C Makwe; A A Abiola; R A Quao; R I Anorlu

doi:10.1007/s13224-020-01374-w

Epigenetic Modification in Methylene Tetrahydrofolate Reductase (MTHFR) Gene of Women with Pre-eclampsia

J Obstet Gynaecol India. 2021 Feb;71(1):52-57. doi: 10.1007/s13224-020-01374-w. Epub 2020 Sep 30.

Authors

V O Osunkalu¹, I A Taiwo², C C Makwe³, A A Abiola¹, R A Quao⁴, R I Anorlu³

Affiliations

¹ Department of Haematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria.
² Department of Obstetrics and Gynaecology, College of Medicine, University of Lagos, Lagos, Nigeria.
³ Department of Cell Biology and Genetics, University of Lagos, Lagos, Nigeria.
⁴ Department of Community Health and Primary Care, Lagos, Nigeria.

Abstract

Background: Genetic and epigenetic factors play significant roles in the aetio-pathogenesis of pre-eclampsia (PE). The effects may vary across racial and geographical boundaries. The role of epigenetic modification in pre-eclampsia was studied among African populations in Lagos, Nigeria.

Aim and objectives: This study aimed to determine the pattern of Methylene tetrahydrofolate reductase gene (MTHFR) CpG island methylation in pre-eclampsia, and evaluate associated covariates.

Methodology: This study was an observational, cross-sectional, study conducted at the Lagos University Teaching Hospital and the Lagos State Island Maternity Hospital. A total of 400 pregnant women consisting of 200 pregnant women diagnosed with pre-eclampsia (study group) and 200 pregnant normotensive and apparently healthy women (control group) were recruited for the study. Demographic and clinical histories were obtained through questionnaires. The DNA Methylation status of the CpG Island in promoter region of the MTHFR gene was assessed using bisulphite conversion and methylation specific PCR method. The biochemical parameters measured in the study were: red cell folate, vitamin B12, plasma homocysteine (Hcy) and methylene tetrahydrofolate reductase enzyme level.

Results: Homozygous MTHFR CpG island hypomethylation pattern was significantly associated with pre-eclampsia (χ ² = 22.96; p = 0.000), Mean values of plasma homocysteine in PE women with homozygous hypomethylation (26.1 ± 9.1 umol/L) were significantly higher than (20.1 ± 4.2 umol/L) observed in PE subjects with homozygous hypermethylation (p = 0.008). Homozygous CpG island hypomethylated pattern of the MTHFR promoter region, was associated with the lowest median MTHFR enzyme level (72.8 ± 39.8 pmol/L) compared with heterozygous methylated pattern (91.3 ± 60.9 pmol/L; p = 0.047) and homozygous methylated pattern (82.3 ± 31.0 pmol/L; 0.047). Red cell folate and Vitamin B12 levels were not significantly associated with CpG island methylation status.

Conclusion: Epigenetic modification plays significant role in the pathogenesis of pre-eclampsia.

Keywords: Epigenetics; Homocysteine; Methylation; Methylene tetrahydrofolate reductase; Pre-eclampsia.